Table 4 Median, minimum and maximum values of cholesteryl ester (CE) species in patients with PCSK9 levels below and above the median level. *P < 0.05, ** P < 0.01
PCSK9 (ng/mL) and CE species (μmol/L) | SVP PCSK9 below the median level (16 patients) | SVP PCSK9 above the median level (15 patients) | P-value | ||||
|---|---|---|---|---|---|---|---|
| Â | Median | Min | Max | Median | Min | Max | Â |
PCSK9 | 101.7 | 9.4 | 148.2 | 211.1 | 156.8 | 1362.3 | ** |
CE 14:0 | 15.3 | 7.0 | 28.6 | 15.3 | 5.2 | 25.0 | Â |
CE 15:0 | 5.1 | 2.3 | 11.8 | 4.4 | 1.6 | 7.6 | Â |
CE 16:1 | 110.3 | 43.8 | 213.5 | 94.5 | 37.3 | 200.5 | Â |
CE16:0 | 256.4 | 100.4 | 418.9 | 177.7 | 71.4 | 285.5 | * |
CE18:3 | 21.5 | 12.2 | 61.6 | 21.4 | 6.5 | 40.5 | Â |
CE 18:2 | 839.7 | 385.5 | 1817.4 | 611.3 | 248.6 | 1200.1 | Â |
CE 18:1 | 381.2 | 168.1 | 672.9 | 307.3 | 105.2 | 452.8 | Â |
CE 18:0 | 5.6 | 3.1 | 21.7 | 6.1 | 2.3 | 13.8 | Â |
CE 20:5 | 8.9 | 3.4 | 18.9 | 4.7 | 2.3 | 8.8 | ** |
CE 20:4 | 123.3 | 34.9 | 214.4 | 54.9 | 23.1 | 102.9 | ** |
CE 20:3 | 12.1 | 3.5 | 35.5 | 8.8 | 3.5 | 15.6 | Â |
CE 20:2 | 0.9 | 0.4 | 2.9 | 0.7 | 0.0 | 1.6 | Â |
CE 20:1 | 0.6 | 0.3 | 2.8 | 0.5 | 0.2 | 1.9 | Â |
CE 20:0 | 0.8 | 0.5 | 1.5 | 0.7 | 0.6 | 1.1 | Â |
CE 22:6 | 6.4 | 2.1 | 14.8 | 3.9 | 1.9 | 8.9 | ** |
CE 22:5 | 1.3 | 0.3 | 2.9 | 0.9 | 0.5 | 2.6 | Â |
CE 22:4 | 0.5 | 0.2 | 1.6 | 0.4 | 0.0 | 1.3 | * |
CE 22:1 | 0.4 | 0.2 | 1.4 | 0.3 | 0.0 | 0.7 | Â |